ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program (Q44462012)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program |
scientific article |
Statements
1 reference
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program (English)
1 reference
A G Pallis
1 reference
D Mavroudis
1 reference
N Androulakis
1 reference
J Souglakos
1 reference
C Kouroussis
1 reference
V Bozionelou
1 reference
I G Vlachonikolis
1 reference
V Georgoulias
1 reference
1 June 2003
1 reference
1 reference
40
1 reference
3
1 reference
301-307
1 reference
Identifiers
1 reference
1 reference